FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Experimental Peptide Creates Risk for Athletes FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC